Stock comparison
AMGEN INC is 22.7x more valuable than Vaxcyte, Inc. by market capitalization ($196.28 B vs $8.64 B). Compare market value, revenue, profit, margins, filings, and source pages in one place.
Quick answer
AMGN is larger
AMGEN INC is 22.7x more valuable than Vaxcyte, Inc. by market capitalization ($196.28 B vs $8.64 B).
Market value leader
AMGN
AMGEN INC is 22.7x more valuable than Vaxcyte, Inc. by market capitalization ($196.28 B vs $8.64 B).
Profit leader
AMGN
PCVX: -$766.63K vs AMGN: $7.71B.
| Metric | PCVX | AMGN |
|---|---|---|
| Market cap | $8.64 B | $196.28 B |
| US-listed rank | #1046 | #75 |
| Revenue (latest FY) | - | $36.75B |
| Net income (latest FY) | -$766.63K | $7.71B |
| Net margin | - | 21.0% |
| P/E (trailing FY) | - | 25.5x |
| SEC filings | 681 | 1,011 |
Jump from this comparison into the underlying pages for market value, annual fundamentals, and company filing history.
Market cap uses refreshed market data. Revenue, net income, margins, and trailing fiscal-year P/E use annual company facts from filings. If a metric is missing, the source data did not have a clean recent annual value for that company.
AMGEN INC is 22.7x more valuable than Vaxcyte, Inc. by market capitalization ($196.28 B vs $8.64 B).
Full pages: Vaxcyte, Inc. and AMGEN INC, or browse the full rankings.